Clinical Trials Directory

Trials / Conditions / Stage IIC Ovarian Cancer

Stage IIC Ovarian Cancer

9 registered clinical trials studyying Stage IIC Ovarian Cancer.

StatusTrialSponsorPhase
WithdrawnSirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Perito
NCT02833506
Roswell Park Cancer InstitutePhase 1
CompletedIntravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian C
NCT03297489
Roswell Park Cancer InstituteEARLY_Phase 1
CompletedCarevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
NCT03198286
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityN/A
CompletedVaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Pri
NCT01606241
Mayo ClinicPhase 1
CompletedVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
NCT01522820
Roswell Park Cancer InstitutePhase 1
TerminatedGranisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherap
NCT01275664
Gynecologic Oncology GroupN/A
CompletedOPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Ca
NCT00857545
Gynecologic Oncology GroupPhase 2
CompletedChanges in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone
NCT01080521
Gynecologic Oncology Group—
CompletedCollecting Tumor Samples From Patients With Gynecological Tumors
NCT00897442
Gynecologic Oncology Group—